The treatment and prevention of acute ischemic stroke

The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue Plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-7.

Kay R, Wong KS, Yu YL, et al. Low-molecular-weight heparin for the treatment of acute ischemic stroke. N Engl J Med 1995;333:1588-93.

Multicentre Acute Stroke Trial-Italy (MAST-I) Group. Randomised controlled trial of streptokinase, aspirin, and combination of both in the treatment of acute ischaemic stroke. Lancet 1995;346:1509-14.

Longestreth W. Tissue Plasminogen activator improved clinical outcome after acute ischemic stroke - Commentary . Evidence Based Medicine 1996; 4: 106-7.

Pearce KA, Furberg CD, Rushing J. Does antihypertensive treatment of the elderly prevent cardiovascular events or prolong life? A meta-analysis of hypertension treatment trials. Arch Fam Med 1995;4:943-50.

Antiplatelet Trialists' Collaboration. Collaborative overview of randomized therapy - I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994; 308:81-106.